Team of liver health professionals and scientists based in the Freeman Hospital and Institute of Transplantation, Newcastle. Retweets are not endorsements.
5 years of HCV testing & treatment in NE England Prisons. Great Collaborative working.
-High rate of testing & treatment
-HCV viraemia⬇️
-Progress towards Elimination
@NuthHCVTeam @HepatitisCTrust
Journal of Viral Hepatitis | Wiley Online Library https://t.co/ceA9S9SPWu
Great collaborative work between @NuthHCVTeam and @HepatitisCTrust showing the impact of a Hepatitis C 'test, trace and treat' programme using peer workers
Journal of Viral Hepatitis | Wiley Online Library https://t.co/zuV3nJIWPs
New research - Huang et al - Type 2 diabetes, hepatic decompensation & hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis
https://t.co/nEsc8Vs6AJ
#LiverTwitter#Diabetes#NAFLD#MASLD
Honorary @EASLnews President Professor Maggie Bassendine (who I had the pleasure of working under @LiverUnit) gives an overview of the main changes since early days of Association. Highlights gender equality - some progress but still a way to go! #EASLCongress
Come a join us at the Newcastle Liver Unit as a research fellow in fatty liver with @QAnstee. A fantastic project for a motivated individual. Further details can be found at: https://t.co/uCCCM0YBlJ
What can you do when all treatment options have failed for chronic #hepatitisE and the patients has progressed to advanced fibrosis? Ledipasvir/sofosbuvir and ribavirin may be worth a try. https://t.co/ikTKmRIJmp #LiverTwitter@BASLedu@EASLedu
Nice work from @SamJTingle looking at the impact of Donor Liver Blood tests on outcomes from liver transplantation. Peak ALT does not predict outcomes. https://t.co/sI2wQcx9vs
Nonalcoholic fatty liver disease is a highly prevalent & largely asymptomatic disease posing a major healthcare challenge. There's an urgent need for more sensitive, specific, independently validated & qualified biomarkers for use in #NAFLD.
#UEGEdu ➡️ https://t.co/FYGPGSQ770
First results from the @LITMUS_IMI metacohort
❓Accuracy of 17 biomarkers in 966 adults w/ #NAFLD; 335 (35%) w/ at-risk #NASH
❌None met predefined acceptable AUC in detecting at-risk NASH (NAS≥4 & F≥2)
✅SomaSignal & ADAPT exceeded criteria for detecting F≥3
#livertwitter
Extremely productive #UKCLIF meeting! There are clearly challenges delivering research to improve care and outcomes for UK patients with decompensated cirrhosis, but there is enthusiasm to work collaboratively and innovate! Contact us to get involved! @RajivJalan1@drgautammehta
We're proud to be working as part of the Obesity Health Alliance.
📺 80% of UK adults support the banning of advertising of unhealthy food on TV & online to kids.
🥤 68% would support an industry levy being extended beyond soft drinks.
Read more: https://t.co/ttwMf9xwvF
Final our NIHR funded study is out!!!
RFA primary ☑️ secondary ❎
Clinical and cost effectiveness of endoscopic bipolar radiofrequency ablation for the treatment of malignant biliary obstruction: a systematic review. Health Technol Assess. 2023 May;27(7):1-118.
In honour of #EuroTestWeek I am celebrating exceptional people committed to testing. Todays #HepC hero is the wonderful Kate @FreemanHospital whose diligence in tracking & tracing people is phenomenal. Kate will help ensure no one gets left behind in the #HepCULater mission.